Showing 601 - 620 results of 9,864 for search '"drug"', query time: 0.10s Refine Results
  1. 601

    Dysfunctional large-scale brain networks in drug-naïve depersonalization-derealization disorder patients by Sisi Zheng, Mingkang Song, Nan Song, Hong Zhu, Xue Li, Dongqing Yin, Shanshan Liu, Yan Zhao, Meng Fang, Yanzhe Ning, Hongxiao Jia

    Published 2025-01-01
    “…Methods A total of 47 drug-naïve DPRD patients and 49 healthy controls (HCs) were recruited and underwent resting-state functional scanning. …”
    Get full text
    Article
  2. 602
  3. 603

    Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications? by Irene Ruiz-Tamayo, Josep Franch-Nadal, Manel Mata-Cases, Dídac Mauricio, Xavier Cos, Antonio Rodriguez-Poncelas, Joan Barrot, Gabriel Coll-de-Tuero, Xavier Mundet-Tudurí

    Published 2016-01-01
    “…To assess prescribing practices of noninsulin antidiabetic drugs (NIADs) in T2DM with several major contraindications according to prescribing information or clinical guidelines: renal failure, heart failure, liver dysfunction, or history of bladder cancer. …”
    Get full text
    Article
  4. 604

    Depression and anxiety in glaucoma patients using mono drug therapy vs polydrug therapy by Aaiza Tahir, Muhammad Waqas Ahmed, Summaya Khan, Omar Zafar, Muhammad Haroon Sarfraz, Muhammad Shahid Tarar

    Published 2023-06-01
    “…The mean age in the mono-drug group (mean= 48.81±10.58 years) was slightly lower than the polydrug group (mean=53.67±11.16years) (p=0.000018). …”
    Get full text
    Article
  5. 605
  6. 606
  7. 607

    Risk Factors Associated with Pyogenic Spinal Infections among Intravenous Drug Users and Nonusers by Vivek K. Bilolikar, Brendan Gleason, Lee Kripke, Robert Merrill, Colin Whitaker, Jon Handal

    Published 2024-01-01
    “…To identify the differences in patient factors, presentation, treatment course, and outcomes of intravenous drug users (IVDA) vs. nonusers (non-IVDA) presenting with pyogenic spinal infections. …”
    Get full text
    Article
  8. 608

    Development, Characterization, and Pharmacodynamic Evaluation of Hydrochlorothiazide Loaded Self-Nanoemulsifying Drug Delivery Systems by Pankajkumar S. Yadav, Ekta Yadav, Amita Verma, Saima Amin

    Published 2014-01-01
    “…The objective of the current work was to develop optimized self-nanoemulsifying drug delivery systems (SNEDDS) and evaluate their in vitro and in vivo performance. …”
    Get full text
    Article
  9. 609

    Interventions by Cardiovascular Drugs Against Aircraft Noise-Induced Cardiovascular Oxidative Stress and Damage by Marin Kuntić, Ivana Kuntić, Jiayin Zheng, Leonardo Nardi, Matthias Oelze, Arijan Valar, Dominika Mihaliková, Lea Strohm, Henning Ubbens, Qi Tang, Liyu Zhang, Guilherme Horta, Paul Stamm, Omar Hahad, Dilja Krueger-Burg, Huige Li, Sebastian Steven, Adrian Gericke, Michael J. Schmeisser, Thomas Münzel, Andreas Daiber

    Published 2025-01-01
    “…Here, we investigated the protective effects of cardiovascular drug interventions against aircraft noise-mediated cardiovascular complications such as elevated oxidative stress or endothelial dysfunction. …”
    Get full text
    Article
  10. 610

    Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA by Haliza Katas, Maria Abdul Ghafoor Raja, Kai Leong Lam

    Published 2013-01-01
    “…Chitosan nanoparticles (CS NPs) exhibit good physicochemical properties as drug delivery systems. The aim of this study is to determine the modulation of preparative parameters on the physical characteristics and colloidal stability of CS NPs. …”
    Get full text
    Article
  11. 611

    Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol. by Sarah Ann Smith, Shaina Smith, Liz Dennett, Yanbo Zhang

    Published 2024-01-01
    “…Interest in psychedelic drugs has increased in recent years, with significant research identifying psychedelic and hallucinogenic drugs as modulators of social cognition. …”
    Get full text
    Article
  12. 612
  13. 613
  14. 614

    Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes by J. Limo, C. Pahe, I. Kathure, L. Ndungu, A. Mahihu, C. Mwashumbe, E. Mueni, H. Momanyi

    Published 2025-01-01
    “…BACKGROUND: Drug-resistant TB (DR-TB) remains a public health concern in Kenya, with an estimated 2,500 individuals acquiring DR-TB annually. …”
    Get full text
    Article
  15. 615

    Existence of multiple-stable equilibria for a multi-drug-resistant model of mycobacterium tuberculosis by Abba B. Gumel, Baojun Song

    Published 2008-05-01
    Subjects: “…key words and phrases. multi-drug-resistant tb…”
    Get full text
    Article
  16. 616
  17. 617

    Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile by Astri Budikayanti, Lubna Muhammad Qadri, Zakiah Syeban, Luh Ari Indrawati, Fitri Octaviana

    Published 2018-01-01
    “…Adverse events (AEs) associated with antiepileptic drugs (AEDs) affect people with epilepsy’s (PWE) quality of life. …”
    Get full text
    Article
  18. 618
  19. 619

    Oxidation of Paracetamol Drug by a New Oxidant Diperiodatoargentate (III) in Aqueous Alkaline Medium by D. C. Hiremath, C. V. Hiremath, S. T. Nandibewoor

    Published 2006-01-01
    “…The kinetics of oxidation of anti-pyretic drug, paracetamol by diperiodatoargentate (III) (DPA) in alkaline medium at a constant ionic strength of 0.01 mol dm-3 was studied spectrophotometrically. …”
    Get full text
    Article
  20. 620

    Preparation of Biodegradable Silk Fibroin/Alginate Blend Films for Controlled Release of Antimicrobial Drugs by Yaowalak Srisuwan, Yodthong Baimark

    Published 2013-01-01
    “…The dissolution and film transparency of the blend films depended on the SF/alginate blend ratio. The in vitro drug release profile of the blend films was determined by plotting the cumulative drug release versus time. …”
    Get full text
    Article